Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapyDaisuke Nobuoka, Tetsuya Nakatsura, Toshiaki Yoshikawa et al.|Cancer Immunology Immunotherapy|2012Cited by 48
Ki67 expression and localization of T cells after neoadjuvant therapies as reliable predictive markers in rectal cancerKen Imaizumi, Tetsuya Nakatsura, Toshihiro Suzuki et al.|Cancer Science|2019Cited by 39
Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinomaKazuya Ofuji, Tetsuya Nakatsura, Daisuke Nobuoka et al.|Oncotarget|2016Cited by 28
Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican-3-derived peptideYoshitaka Tada, Tetsuya Nakatsura, Toshiaki Yoshikawa et al.|International Journal of Oncology|2013Cited by 25
Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptideTatsuaki Iwama, Tetsuya Nakatsura, Kazutaka Horie et al.|International Journal of Oncology|2013Cited by 20